Switch to side-by-side view

--- a
+++ b/clusters/9knumclustersv2/clust_1567.txt
@@ -0,0 +1,25 @@
+QT interval corrected using Fridericia formula (QTcF) >  msec on average of screening electrocardiograms (EKGs) performed within  days of first dose of cabozantinib; three EKGs must be performed at screening; if the average of these three consecutive results for QTcF is >  msec, the subject is ineligible
+Corrected QT interval by Fredericia (QTcF) >  msec within  month before the first dose of study treatment:\r\n* Three electrocardiograms (ECGs) must be performed for eligibility determination. If the average of these three consecutive results for QTcF is =<  msec, the subject meets eligibility in this regard
+The participant has a corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before randomization; note: if initial QTcF is found to be >  ms, two additional electrocardiogram (ECGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the participant meets eligibility in this regard
+A corrected QT interval calculated by the Fridericia formula (QTcF) >  milliseconds within  days before first dose of study treatment. Three electrocardiograms (ECGs) must be performed for eligibility determination. If the average of these three consecutive results for QTcF is =<  milliseconds, the subject will be eligible.
+Fridericia's corrected QT (QTcF) interval >  msec\r\nNote: Three electrocardiograms (ECGs) must be performed for eligibility determination; if the average of these three consecutive results for QTcF is =<  msec, the subject meets eligibility in this regard
+Corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before starting study treatment\r\n* Note: if the QTcF is >  ms in first electrocardiography (ECG), a total of  ECGs should be performed; if the average of these  consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+Fridericia's correction formula (QTcF) >  msec within  month before the first dose of study treatment:\r\n* Three electrocardiography (ECG)s must be performed for eligibility determination; if the average of these three consecutive results for QTcF is =<  msec, the subject meets eligibility in this regard
+Corrected QT using Fridericia's formula (QTcF) >  msec within  month before the first dose of study treatment:\r\n* Three electrocardiogram (ECG)s must be performed for eligibility determination; if the average of these three\r\nconsecutive results for QTcF is =<  msec, the subject meets eligibility in this regard
+The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before randomization; Note: if initial QTcF is found to be >  ms, two additional electrocardiogram (EKG)s separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before treatment; note: if initial QTcF is found to be >  ms, two additional electrocardiograms (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+QTcF (Fridericia formula for the QT interval correction for the heart rate) >  msec within  weeks of enrollment; if the initial QTcF is found to be >  msec, two additional electrocardiograms (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  msec, the subject meets eligibility in this regard; subjects with history of congenital long QT syndrome, or torsades de pointes, are not allowed
+A corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before first dose of study treatment; three electrocardiograms (ECGs) must be performed; if the average of these three consecutive results for QTcF is =<  msec, the subject meets eligibility in this regard
+The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before randomization; Note: if initial QTcF is found to be >  ms, two additional electrocardiograms (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before randomization; Note: if initial QTcF is found to be >  ms, two additional electrocardiograms (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+Corrected QT interval by Fridericia's formula (QTcF) >  msec within  month before the first dose of study treatment\r\n* Three electrocardiography (ECG)s must be performed for eligibility determination; if the average of these three consecutive results for QTcF is =<  msec, the subject meets eligibility in this regard
+Patients with clinically significant cardiovascular disease; this includes:\r\n* Myocardial infarction or unstable angina within  months prior to registration\r\n* New York heart association (NYHA) class II or greater congestive heart failure\r\n* History of serious ventricular arrhythmia (i.e., ventricular tachycardia or ventricular fibrillation) or serious cardiac arrhythmia requiring medication; this does not include asymptomatic atrial fibrillation with controlled ventricular rate\r\n* Any history of congenital long QT syndrome\r\n* The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before randomization; Note: if initial QTcF is found to be >  ms, two additional electrocardiogram (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+A corrected QT interval calculated by the Fridericia formula (QTcF) =<  ms within  days before randomization; Note: if initial QTcF is found to be >  ms, two additional electrocardiograms (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the patient meets eligibility in this regard
+Corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before start of treatment; Note: at baseline (i.e. screening), three ECGs to be obtained within  minutes but approximately  to  minutes apart (i.e. triplicate); if the average of the three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+Corrected QT interval using Fridericia's formula (QTcF) >  msec within  weeks of enrollment; if the initial QTcF is found to be >  ms, two additional electrocardiograms (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+Patients with clinically significant cardiovascular disease; this includes: \r\n* Uncontrolled hypertension, defined as systolic greater than or equal to  mm Hg or diastolic greater than or equal to  mm Hg despite antihypertensive medications \r\n* Myocardial infarction or unstable angina within  months prior to the first date of study treatment\r\n* New York Heart Association (NYHA) class II or greater congestive heart failure\r\n* History of serious ventricular arrhythmia (i.e., ventricular tachycardia or ventricular fibrillation) or serious cardiac arrhythmia requiring medication; this does not include asymptomatic atrial fibrillation with controlled ventricular rate\r\n* Corrected QT interval calculated by the Fridericia formula (QTcF) >  ms; \r\n** Note: if initial QTcF is found to be >  ms, two additional electrocardiograms (ECGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is less than or equal to  ms, the subject meets eligibility in this regard
+The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) >  milliseconds (ms) within  days before initiation of cabozantinib; Note: if initial QTcF is found to be >  ms, two additional electrocardiograms (EKGs) separated by at least three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before initiation of protocol therapy; Note: if initial QTcF is found to be >  ms, two additional electrocardiograms (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before day  of cycle ; note: if initial QTcF is found to be >  ms, two additional electrocardiograms (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard
+Cardiovascular disorders including:\r\n* Congestive heart failure (CHF): New York Heart Association (NYHA) class III (moderate) or class IV (severe) at the time of screening\r\n* Concurrent uncontrolled hypertension defined as sustained blood pressure (BP) >  mm Hg systolic, or >  mm Hg diastolic despite optimal antihypertensive treatment within  days of the first dose of study treatment\r\n* The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before randomization; Note: if initial QTcF is found to be >  ms, two additional electrocardiograms (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard\r\n* Any history of congenital long QT syndrome\r\n* Any of the following within  months before the first dose of study treatment:\r\n** Unstable angina pectoris\r\n** Clinically-significant cardiac arrhythmias\r\n** Stroke (including transient ischemic attack [TIA], or other ischemic event)\r\n** Myocardial infarction\r\n** Cardiomyopathy
+The subject has a corrected QT interval calculated by the Fridericia formula (QTcF) >  ms within  days before enrollment; note: if initial QTcF is found to be >  ms, two additional electrocardiograms (EKGs) separated by at least  minutes should be performed; if the average of these three consecutive results for QTcF is =<  ms, the subject meets eligibility in this regard